INFINITY PHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Infinity Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q2 2023.
  • Infinity Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2023 was 90.8M shares, a 1.66% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 90.8M +1.48M +1.66% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 89.4M +267K +0.3% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 89.4M +256K +0.29% Dec 31, 2022 10-Q 2023-08-10
Q3 2022 89.3M +414K +0.47% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 89.3M +558K +0.63% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 89.2M +508K +0.57% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 89.2M +24.8M +38.6% Dec 31, 2021 10-K 2023-03-28
Q3 2021 88.9M +25.8M +40.8% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 88.7M +31.2M +54.3% Jun 30, 2021 10-Q 2021-07-27
Q1 2021 88.6M +31.2M +54.3% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 64.3M +7.24M +12.7% Dec 31, 2020 10-K 2022-03-29
Q3 2020 63.1M +6.11M +10.7% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 57.5M +467K +0.82% Jun 30, 2020 10-Q 2020-07-30
Q1 2020 57.4M +508K +0.89% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 57.1M +170K +0.3% Dec 31, 2019 10-K 2021-03-16
Q3 2019 57M +173K +0.31% Sep 30, 2019 10-Q 2019-10-30
Q2 2019 57M +193K +0.34% Jun 30, 2019 10-Q 2019-07-30
Q1 2019 56.9M +3.23M +6.01% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 56.9M +6.15M +12.1% Dec 31, 2018 10-K 2020-03-03
Q3 2018 56.9M +6.17M +12.2% Sep 30, 2018 10-Q 2018-11-05
Q2 2018 56.8M +6.35M +12.6% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 53.7M +3.27M +6.49% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 50.8M +386K +0.77% Dec 31, 2017 10-K 2019-03-14
Q3 2017 50.7M +1.1M +2.22% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 50.5M +974K +1.97% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 50.4M +1.08M +2.18% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 50.4M +1.07M +2.17% Dec 31, 2016 10-K 2018-03-15
Q3 2016 49.6M +390K +0.79% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 49.5M +344K +0.7% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 49.3M +321K +0.65% Mar 31, 2016 10-Q 2016-05-04
Q4 2015 49.3M +426K +0.87% Dec 31, 2015 10-K 2017-03-14
Q3 2015 49.2M +473K +0.97% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 49.2M +579K +1.19% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 49M +510K +1.05% Mar 31, 2015 10-Q 2015-05-06
Q4 2014 48.9M +651K +1.35% Dec 31, 2014 10-K 2016-02-23
Q3 2014 48.7M +639K +1.33% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 48.6M +603K +1.26% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 48.5M +689K +1.44% Mar 31, 2014 10-Q 2014-05-06
Q4 2013 48.2M +729K +1.53% Dec 31, 2013 10-K 2015-02-24
Q3 2013 48.1M +8.61M +21.8% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 48M +20.7M +76% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 47.8M +20.9M +77.9% Mar 31, 2013 10-Q 2013-05-07
Q4 2012 47.5M +20.8M +77.8% Dec 31, 2012 10-K 2014-02-25
Q3 2012 39.5M +12.8M +48% Sep 30, 2012 10-Q 2012-11-06
Q2 2012 27.3M +667K +2.51% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 26.9M Mar 31, 2012 10-Q 2012-05-08
Q4 2011 26.7M +203K +0.76% Dec 31, 2011 10-K 2013-03-05
Q3 2011 26.7M Sep 30, 2011 10-Q 2011-11-08
Q2 2011 26.6M Jun 30, 2011 10-Q 2011-08-09
Q4 2010 26.5M Dec 31, 2010 10-K 2012-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.